NCT02943460.
Trial name or title | NCT02943460. |
Methods | Randomised, double‐blind, placebo‐controlled trial. |
Participants | Patients with primary sclerosing cholangitis. |
Interventions | GS‐9674 vs placebo. |
Outcomes | Adverse events. |
Starting date | November 2016. |
Contact information | GS‐US‐428‐4025@Gilead.com |
Notes |